The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
what do you think, will he pay for our shates ?
whats up with sarossa ? squeeze out ?
http://www.investegate.co.uk/sarossa-plc--sars-/rns/holding-…
Hello, did you c any future for sarossa ? Best Regards from Germany
http://m.londonstockexchange.com/exchange/mobile/news/detail.html?announcementId=11464266
During the quarter notable new investments include: ASM, Symphony International, Kinnevik and Dundee Corp. ASM is a European technology holding company which could potentially be restructured. We purchased Symphony International, a UK listed investment trust with Asian focussed consumer assets, during a deeply discounted placing. Despite the subsequent rise in its share price, it is currently trading on a 43% discount. Kinnevik, a Swedish listed holding company with interests in listed telecom companies and unlisted e-commerce businesses is trading on a 35% discount. Dundee Corp is a Canadian listed holding company with significant investments in real estate, resources, financial assets and agriculture. Dundee is trading on a 26% discount and the management has a proven record of restructuring assets.
How High is the Dividend fore One antisoma Share ? Best Regards Germany
hi, is there something with News ??? best regards
Have anybody the Name of the Health Care Company ? A Million £ is investet there !!!!
Sounds Good, waiting for Informations : 25 Oct.
Is there a Stockholder, with any News about Antisoma ? Message Box via Telephone is Full. You can Leave no Message there. Email ? Best Regards Gerald
RNS Number : 0710V AIM 05 January 2012  ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") COMPANY NAME: Antisoma plc COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) : Mitre House, 160 Aldersgate Street, London, EC1A 4DD COUNTRY OF INCORPORATION: England COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26: www.antisoma.com COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: The directors of Antisoma plc (the "Company") (the "Directors") expect the Company to be classified as an investing company upon the Admission of its ordinary shares to AIM. In anticipation of this, the shareholders of the Company approved a formal investing policy at a general meeting on 7 December 2011. Details of the investing policy are set out below: The Directors intend to identify investment opportunities offering the potential to deliver a favourable return to the Company's shareholders over the medium term, primarily in the form of a capital gain. A particular consideration will be to identify businesses which, in the opinion of the Directors, are under-performing and present opportunities for value creation. The Company's equity interest in a potential investment may range from a minority position to 100 per cent. ownership and the interest may be either quoted or unquoted. The Directors intend to be active investors and to assist in the strategic development and growth of significant acquisitions and/or investments made by the Company. The acquisitions or investments may be funded from existing cash resources, by the issue of new ordinary shares or with debt, or a combination thereof, as the Directors deem appropriate. It is anticipated that returns to shareholders will be delivered principally through capital growth rather than capital distributions via dividends, although it may become appropriate to distribute funds to shareholders once the Company's investments mature. The Directors are at an early stage of screening potential opportunities but have not, at this stage, commissioned any due diligence nor entered into any firm commitment in connection with any acquisitions or investments. Initial due diligence will be carried out by the Directors who may subsequently commission third party due diligence as appropriate. DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasur
Happy New Year for everybody ! Why is M Pappas buying near a Million Shares, is there anything to know about it ? Any thougths ?????
Excuse me, Is that a bad message for us ???
www.investegate.co.uk/Article.aspx?id=201111031446384642R Os that a bad massage for us ?
www.investegate.co.uk/Article.aspx?id=201108081003389210L www.investegate.co.uk/Article.aspx?id=201108081003389210L
iam holding 32000 shares. hope it works for us
we in Germany are waiting for news, about the future. is a takeover possible ? what did you think about ? Gerald